¼ø»ÆÊ¦app/Cleveland Clinic Florida
The collaborative research training agreement between ¼ø»ÆÊ¦app (¼ø»ÆÊ¦app) and the offers an exceptional opportunity for Ph.D. ¼ø»ÆÊ¦app to engage in cutting-edge biomedical research. This program is open to highly qualified ¼ø»ÆÊ¦app enrolled in ¼ø»ÆÊ¦app’s Ph.D. in Integrative Biology or Ph.D. in Chemistry programs.
Through this partnership, selected ¼ø»ÆÊ¦app will have the opportunity to conduct research at the Cleveland Clinic Florida Research and Innovation Center (FRIC) in Port St. Lucie, with a focus on infectious diseases and the development of novel immunotherapies.
Application Deadline:
December 11 for fall admission
Apply here:
For more information, please contact:
Ken You Morisseau
Academic Coordinator, Integrative Biology Ph.D. Program
kmorisseau2014@fau.edu
Application Deadline:
February 15 (International) and April 15 (Domestic) for fall admission
July 15 (International) and November 1 (Domestic) for spring admission
Apply here:
For more information, please contact:
Mare Cudic, Ph.D.
Professor and Director of Graduate Programs,
Department of Chemistry and Biochemistry
mcudic@fau.edu
Biology Faculty
Dhiraj Acharya, Ph.D.
Area of Emphasis: Emerging viral pathogens, Antiviral immune responses, and Virus-host interactions
Younho Choi, Ph.D.
Area of Emphasis: Tick-borne viruses, SARS-CoV-2
Michaela Gack, Ph.D.
Area of Emphasis: Innate immunity to virus infection, Viral immune evasion, host-based antiviral therapeutics
Kun Li, Ph.D.
Area of Emphasis: Coronaviruses
Ted Ross, Ph.D.
Area of Emphasis: Universal influenza vaccine design, other viral vaccines
Giuseppe Sautto, Ph.D.
Area of Emphasis: Immuno-therapeutics
Emily Speranza, Ph.D.
Area of Emphasis: Viral immunology, Host virus interactions
Jun Zhao, Ph.D.
Area of Emphasis: Tumor virology, Metabolomics, Preclinical infection models
Chemistry Faculty
Michaela Gack, Ph.D.
Area of Emphasis: Innate immunity to virus infection, Viral immune evasion, host-based antiviral therapeutics
Giuseppe Sautto, Ph.D.
Area of Emphasis: Immuno-therapeutics